Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Co-Lifecycle Governance for Learning Medical AI: A Hybrid Convergence Framework for Adaptive Regulatory Oversight.

Journal of medical Internet research·2026

Same author

Diverging regulatory DNA in adaptive medical AI: US agility and EU accountability in lifecycle governance.

Frontiers in medicine·2026

Same author

Effectiveness of a 52-week multidomain intervention to maintain cognitive function in patients with mild cognitive impairment: a randomized controlled trial.

Scientific reports·2025

Same author

Effects of astrocytic PKM2 gene deletion on neuronal death following traumatic brain injury.

Cell death discovery·2025

Same author

Risk factors for prediabetes in young adults: a study based on Korea National health and nutrition examination survey data.

Scientific reports·2025

Same author

Effects of Microplastic Accumulation on Neuronal Death After Global Cerebral Ischemia.

Cells·2025

Same journal

DiffGRN: differential gene regulatory network analysis.

International journal of data mining and bioinformatics·2019

Same journal

Integration of multi-omics data for integrative gene regulatory network inference.

International journal of data mining and bioinformatics·2018

Same journal

The development of non-coding RNA ontology.

International journal of data mining and bioinformatics·2016

Same journal

Learning multiple distributed prototypes of semantic categories for named entity recognition.

International journal of data mining and bioinformatics·2015

Same journal

Weighted fusion regularisation and predicting microbial interactions with vector autoregressive model.

International journal of data mining and bioinformatics·2015

Same journal

Application of consensus string matching in the diagnosis of allelic heterogeneity involving transposition mutation.

International journal of data mining and bioinformatics·2015

See all related articles

Search research articles

Related Experiment Video

Updated: May 16, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Selecting SNPs for pharmacogenomic association study.

Tae Jin Ahn¹, Kyunghee Park, Dae-Soon Son

¹Interdisciplinary Program in Bioinformatics, Seoul National University, Gwanak-gu, Seoul 151-742, Korea. taejin.ahn@samsung.com

International Journal of Data Mining and Bioinformatics

|November 20, 2012

Summary

This summary is machine-generated.

Intelligent selection of single nucleotide polymorphism (SNP) genotyping content is crucial for personalized medicine. A new algorithm enhances SNP genotyping device value by optimizing content selection for cancer and pharmacogenomic studies.

More Related Videos

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Related Experiment Videos

Last Updated: May 16, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Area of Science:

Genomics
Personalized Medicine
Bioinformatics

Background:

Single nucleotide polymorphism (SNP) genotyping is vital for personalized genome analysis and medicine.
Current SNP genotyping devices have limited capacity (1 million SNPs) compared to the human genome's vast number of SNPs (over 10 million).
Optimizing SNP content selection is necessary to maximize the utility of genotyping devices.

Purpose of the Study:

To develop a novel algorithm for intelligent SNP content selection.
To design optimized genotyping content for cancer and pharmacogenomic association studies.
To enhance the value and performance of SNP genotyping devices.

Main Methods:

Development of a new SNP selection algorithm.
Application of the algorithm to design genotyping content.
Comparative analysis against existing SNP genotyping products.

Main Results:

The developed algorithm enables intelligent selection of SNP content.
Genotyping content designed using this method showed increased product value.
The approach outperformed competitive SNP genotyping products in terms of value.

Conclusions:

The new selection algorithm significantly enhances the value of SNP genotyping devices.
This method is effective for designing content for cancer and pharmacogenomic association studies.
Optimized SNP content selection is key to advancing personalized genome applications.